GlassScriptPhysician profile
Alexandr Aylyarov
NPI 1164884680
$22,411.88
in general payments reported to CMS, 2019-2025
13 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,424 · 2022: $7,821 · 2023: $3,469 · 2024: $2,596 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,130 · Food and Beverage: $2,017 · Education: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,130.40 |
| Food and Beverage | $2,017.35 |
| Education | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,875.03 | 2021-2022 | |
| Arthrex, INC. | $5,888.94 | 2022-2025 | Extremities & Trauma Implants Long Bone Trauma Femoral Fracture |
| Medical Device Business Services, INC. | $2,984.07 | 2021 | |
| Anika Therapeutics, INC. | $1,590.85 | 2023-2024 | Revomotion, Ovo Motion, Inlay Glenoid 2.0 |
| Medacta USA, INC. | $1,198.80 | 2023 | Primary Shoulder |
| Zimmer Biomet Holdings, INC. | $807.37 | 2022-2023 | Tapestry |
| Southern Edge Orthopaedics, INC. | $464.82 | 2023-2024 | |
| Stryker Corporation | $372.45 | 2022-2023 | T2 Alpha, Aequalis Perform+, Augment Injectable |
| Biotissue Holdings INC. | $68.62 | 2023 | |
| Vericel Corporation | $68.44 | 2023-2024 | Maci |
| Depuy Synthes Sales INC. | $46.17 | 2023 | Monovisc, Orthovisc |
| Vertex Pharmaceuticals Incorporated | $24.34 | 2025 | |
| Solventum Corporation | $21.98 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandr Aylyarov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.